Berberine-induced haemolysis revisited: Safety of Rhizoma coptidis and cortex phellodendri in chronic haematological diseases

Phytotherapy Research

Volumn 26, Issue 5, 2012, Pages 682-686

  Linn, Yeh Ching ^a   Lu, Jiahui ^b   Lim, Lay Cheng ^a   Sun, Huili ^c   Sun, Jue ^c   Zhou, Yongming ^b   Ng, Han Seong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Yueyang Hospital   (China)

^c Bao Zhong Tang TCM Center   (Singapore)

Author keywords

Cortex phellodendri; glucose 6 phosphate dehydrogenase deficiency; hyperbilirubinemia; neonatal jaundice; Rhizoma coptidis; thalassemia

Indexed keywords

BERBERINE; BILIRUBIN; CHINESE DRUG; CORTEX PHELLODENDRI EXTRACT; RHIZOME COPTIDIS EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTEX PHELLODENDRI; DISEASE EXACERBATION; DRUG SAFETY; DRUG USE; ELECTROLYTE DISTURBANCE; HEMATOLOGIC DISEASE; HEMOLYSIS; HERBAL CONCOCTION; HERBAL MEDICINE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER DYSFUNCTION; MEDICAL PROCEDURES; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RHIZOME COPTIDIS; THALASSEMIA INTERMEDIA; TOXICITY; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BERBERINE; BILIRUBIN; CHRONIC DISEASE; COHORT STUDIES; COPTIS; DRUGS, CHINESE HERBAL; HEMATOLOGIC DISEASES; HEMOLYSIS; HUMANS; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PHELLODENDRON; PLANT BARK; PLANT EXTRACTS; RHIZOME; SINGAPORE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859891677     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3617     Document Type: Article

References (31)

1. Advani R, Sorenson S, Shinar E, Lande W, Rachmilewitz E, Schrier SL,. 1992. Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. Blood 79: 1058-1063.
2. Barosi G, Bordessoule D, Briere J, et al,. 2005. Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET). Blood 106: 2849-2853. (Pubitemid 41510763)
3. Chan E,. 1993. Displacement of bilirubin from albumin by berberine. Biol Neonate 63: 201-208. (Pubitemid 23170617)
4. Chan TY,. 1994. The prevalence use and harmful potential of some Chinese herbal medicines in babies and children. Vet Hum Toxicol 36: 238-240. (Pubitemid 24177993)
5. Cheson BD, Bennett JM, Kantarjian H, et al,. 2000. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 96: 3671-3674.
6. Commission of the Ministry of Public Health. 2000. Pharmacopoeia of the People's Republic of China. Chemical Industry Press: Beijing, 214.
7. Ding J,. 2002. Allergic reaction induced by Berberine hydrochloride tablet. Herald Med 21: 708.
8. Gao X, Chen F, Yang S, et al,. 2002. A review on the causation and prevention of haemolytic jaundice by Huanglian. China J Chin Mat Med 27: 70-74.
9. Ko CH, Li K, Ng PC, et al,. 2008. Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro. Toxicol In Vitro 22: 1222-1227.
10. Li H, Chai X,. 2008. New clinical application of Berberine and its adverse reactions. Med J Chin People's Arm Pol Forces 19 (7): 661-663.
11. Lin N, Gao X, Li J, Zhu J,. 1998. Influence of huanglian and berberine on the erythrocytic osmotic fragility of experimental glucose-6-phosphate dehydrogenase (G6PD) deficiency in rates. China J Chin Mat Med 23: 562-564.
12. Lin X, Lin N, Liu C-f, et al,. 2007. Investigation of Coptis Chinensis on jaundice of glucose-6-phosphate dehydrogenase (G-6PD) deficient neonates from Guigang, Guangxi province. China J Chin Mat Med 32: 2543-2545.
13. Linn YC, Lu JH, Lim LC, Sun HL, Sun J, Zhou YM,. 2011. Traditional Chinese herbal medicine in the supportive management of patients with chronic cytopaenic marrow diseases-a phase I/II clinical study. Compl Ther Clin Prac 17: 152-156.
14. National Toxicology Program. 2010. Studies on goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice. In NTP Technical Report on the Toxicology and Carcinogenesis. NTP TR 562, NTP Publication No. 10-5903; 1-190.
15. Schrezenmeier H, Bacigalupo A, Aglietta M, et al,. 2000. Aplastic Anemia, Pathophysiology and Treatment. Cambridge University Press: Cambridge, 315.
16. Scott MD, van den Berg JJ, Repka T, et al,. 1993. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest 91: 1706-1712. (Pubitemid 23127376)
17. Sun X, Zhang X, Hu H, et al,. 2009a. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 32: 1533-1537.
18. Sun Y, Xun K, Wang Y, Chen X,. 2009b. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20: 757-769.
19. Tai FF,. 2001. Neonatal jaundice-traditional Chinese medicine approach. J Perinatol 21: s98-s100.
20. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y,. 2009. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17.
21. Valaes T,. 1994. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl 394: 58-76. (Pubitemid 24199849)
22. Wang R, Lin N,. 2010. Research of coptis effect on incidence of neonatal jaundice based on Cox model. China J Chin Mat Med 35: 1335-1338.
23. William RB, Wong HB,. 1968. Hyperbilirubinemia and kernicterus in glucose-6-phosphate dehydrogenase-deficient infants in Singapore. Pediatrics 41: 1055-1062.
24. Wong HB,. 1957. Kernikterus not associated with haemolytic disease. Arch Dis Child 32: 85-90.
25. Wong HB,. 1979. Singapore kernicterus. J Singapore Paediatr Soc 21: 218-231. (Pubitemid 11006558)
26. Wong HB,. 1980. Singapore kernicterus. Singapore Med J 21: 556-567. (Pubitemid 11219857)
27. Ye X, Feng Y, Tong Y, et al,. 2009. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol 124: 130-136.
28. Yee SK, Chu SS, Xu YM, Choo PL,. 2005. Regulatory control of Chinese proprietary medicines in Singapore. Health Policy 71: 133-149.
29. Yeung CY, Lee FT, Wong HN,. 1990. Effect of a popular Chinese herb on neonatal bilirubin protein binding. Biol Neonate 58: 98-103. (Pubitemid 20222316)
30. Yin J, Xing H, Ye J,. 2008. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57: 712-717. (Pubitemid 351608234)
31. Zhou JY, Zhou SW, Zhang KB, et al,. 2008. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull 31: 1169-1176. (Pubitemid 351871171)